PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Smida, Michal ^a,b   Cammann, Clemens ^a   Gurbiel, Slavyana ^a   Kerstin, Nadja ^a   Lingel, Holger ^a   Lindquist, Sabine ^c,d   Simeoni, Luca ^a   Brunner Weinzierl, Monika C ^a   Suchanek, Miloslav ^e   Schraven, Burkhart ^a,f   Lindquist, Jonathan A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^e EXBIO Praha   (Czech Republic)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Cell activation; Human; Protein kinases; T cells; Tolerance

Indexed keywords

ADAPTOR PROTEIN; CSK BINDING PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID RAFT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84876946146     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-28     Document Type: Article

References (66)

1. The enemy within: keeping self-reactive T cells at bay in the periphery. Walker LS, Abbas AK, Nat Rev Immunol 2002 2 11 19 10.1038/nri701 11908514 (Pubitemid 37328771)
2. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Acuto O, Bartolo VD, Michel F, Nat Rev Immunol 2008 8 699 712 10.1038/nri2397 18728635
3. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Palacios EH, Weiss A, Oncogene 2004 23 7990 8000 10.1038/sj.onc.1208074 15489916 (Pubitemid 39468856)
4. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. Brdicka T, Pavlistová D, Leo A, Bruyns E, Korínek V, Angelisová P, J Exp Med 2000 191 1591 1604 10.1084/jem.191.9.1591 10790433 (Pubitemid 30257355)
5. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, Tarakhovsky A, Okada M, Nature 2000 404 999 1003 10.1038/35010121 10801129 (Pubitemid 30243594)
6. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. Okada M, Nada S, Yamanashi Y, Yamamoto T, Nakagawa H, J Biol Chem 1991 266 24249 24252 1722201 (Pubitemid 21908933)
7. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT, Nature 1997 385 650 653 10.1038/385650a0 9024665 (Pubitemid 27087580)
8. Crystal structure of the Src family tyrosine kinase Hck. Sicheri F, Moarefi I, Kuriyan J, Nature 1997 385 602 609 10.1038/385602a0 9024658 (Pubitemid 27087567)
9. Three-dimensional structure of the tyrosine kinase c-Src. Xu W, Harrison SC, Eck MJ, Nature 1997 385 595 602 10.1038/385595a0 9024657 (Pubitemid 27087566)
10. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Davidson D, Bakinowski M, Thomas ML, Horejsi V, Veillette A, Mol Cell Biol 2003 23 2017 2028 10.1128/MCB.23.6. 2017-2028.2003 12612075 (Pubitemid 36278813)
11. Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes. Baumgartner M, Angelisová P, Setterblad N, Mooney N, Werling D, Horejsí V, Langsley G, Blood 2003 101 1874 1881 10.1182/blood-2002- 02-0456 12411311 (Pubitemid 36237588)
12. Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Tauzin S, Ding H, Khatib K, Ahmad I, Burdevet D, van Echten-Deckert G, Blood 2008 111 2310 2320 10.1182/blood-2007- 05-090985 18070987 (Pubitemid 351451439)
13. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src. Oneyama C, Hikita T, Enya K, Dobenecker MW, Saito K, Nada S, Mol Cell 2008 30 426 436 10.1016/j.molcel.2008.03.026 18498747 (Pubitemid 351672379)
14. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Tedoldi S, Paterson JC, Hansmann ML, Natkunam Y, Rüdiger T, Angelisova P, Blood 2006 107 213 221 10.1182/blood-2005-06-2273 16160011 (Pubitemid 43053546)
15. A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation. Smida M, Posevitz-Fejfar A, Horejsi V, Schraven B, Lindquist JA, Blood 2007 110 596 615 10.1182/blood-2006-07-038752 17389760 (Pubitemid 47105398)
16. Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. Brdicková N, Brdicka T, Andera L, Spicka J, Angelisová P, Milgram SL, Horejsí V, FEBS Lett 2001 507 133 136 10.1016/S0014-5793(01)02955-6 11684085 (Pubitemid 33001529)
17. Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. Itoh K, Sakakibara M, Yamasaki S, Takeuchi A, Arase H, Miyazaki M, J Immunol 2002 168 541 544 11777944 (Pubitemid 34049551)
18. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Imamoto A, Soriano P, Cell 1993 73 1117 1124 10.1016/0092-8674(93)90641-3 7685657 (Pubitemid 23180486)
19. Constitutive activation of Src family kinases in mouse embryos that lack Csk. Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Cell 1993 73 1125 1135 10.1016/0092-8674(93)90642-4 8513497 (Pubitemid 23180487)
20. Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development. Xu S, Huo J, Tan JE, Lam KP, Mol Cell Biol 2005 25 8486 8495 10.1128/MCB.25.19.8486-8495.2005 16166631 (Pubitemid 41369170)
21. The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function. Dobenecker MW, Schmedt C, Okada M, Tarakhovsky A, Mol Cell Biol 2005 25 10533 10542 10.1128/MCB.25.23. 10533-10542.2005 16287865 (Pubitemid 41681974)
22. Phosphoprotein associated with glycosphingolipid-enriched microdomains differentially modulates Src kinase activity in brain development. Lindquist S, Langnaese K, Karitkina D, Lerch G, Schraven B, Xavier R, PLoS One 2011 6 23978 10.1371/journal.pone.0023978 21915273
23. Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts. Shima T, Nada S, Okada M, Proc Natl Acad Sci USA 2003 100 14897 14902 10.1073/pnas.2432139100 14645715 (Pubitemid 37517988)
24. A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration. Posevitz-Fejfár A, Smida M, Kliche S, Hartig R, Schraven B, Lindquist JA, Eur J Immunol 2008 38 250 259 10.1002/eji.200636664 18085663
25. Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature CD8+ T cells. Wang X, Simeoni L, Lindquist JA, Saez-Rodriguez J, Ambach A, Gilles ED, J Immunol 2008 180 6703 6712 18453590
26. Many roads lead to oncogene-induced senescence. Courtois-Cox S, Jones SL, Cichowski K, Oncogene 2008 27 2801 2809 10.1038/sj.onc.1210950 18193093 (Pubitemid 351620451)
27. Fyn regulates the duration of TCR engagement needed for commitment to effector function. Filby A, Seddon B, Kleczkowska J, Salmond R, Tomlinson P, Smida M, J Immunol 2007 179 4635 4644 17878361
28. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Duan L, Reddi AL, Ghosh A, Dimri M, Band H, Immunity 2004 21 7 17 10.1016/j.immuni.2004.06.012 15345216 (Pubitemid 38925263)
29. CD28 and CTLA-4 coreceptor expression and signal transduction. Rudd CE, Taylor A, Schneider H, Immunol Rev 2009 229 12 26 10.1111/j.1600-065X.2009. 00770.x 19426212
30. CTLA-4 trafficking and surface expression. Valk E, Rudd CE, Schneider H, Trends Immunol 2008 29 272 279 10.1016/j.it.2008.02.011 18468488
31. A molecular perspective of CTLA-4 function. Teft WA, Kirchhof MG, Madrenas J, Annu Rev Immunol 2006 24 65 97 10.1146/annurev.immunol.24.021605. 090535 16551244
32. CTLA-4 negative signaling via lipid rafts: A new perspective. Rudd CE, Martin M, Schneider H, Sci STKE 2002 128 e18
33. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. Darlington PJ, Baroja ML, Chau TA, Siu E, Ling V, Carreno BM, Madrenas J, J Exp Med 2002 195 1337 1347 10.1084/jem.20011868 12021313 (Pubitemid 34564335)
34. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. Chikuma S, Imboden JB, Bluestone JA, J Exp Med 2003 197 129 135 12515820 (Pubitemid 36110264)
35. Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152). Miyatake S, Nakaseko C, Umemori H, Yamamoto T, Saito T, Biochem Biophys Res Commun 1998 249 444 448 10.1006/bbrc.1998.9191 9712716 (Pubitemid 28431773)
36. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. Chuang E, Lee KM, Robbins MD, Duerr JM, Alegre ML, Hambor JE, J Immunol 1999 162 1270 1277 9973379 (Pubitemid 29306995)
37. Src kinases Fyn and Lck facilitate the accumulation of phosphorylated CTLA-4 and its association with PI-3 kinase in intracellular compartments of T-cells. Hu H, Rudd CE, Schneider H, Biochem Biophys Res Commun 2001 288 573 578 10.1006/bbrc.2001.5814 11676481 (Pubitemid 33030068)
38. High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4). Pandiyan P, Hegel JK, Krueger M, Quandt D, Brunner-Weinzierl MC, J Immunol 2007 178 2132 2140 17277117 (Pubitemid 46233410)
39. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells. Vang T, Abrahamsen H, Myklebust S, Enserink J, Prydz H, Mustelin T, Eur J Immunol 2004 34 2191 2199 10.1002/eji.200425036 15259016 (Pubitemid 39256100)
40. Reversal of the TCR stop signal by CTLA-4. Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, Brewer JM, Science 2006 313 1972 1975 10.1126/science.1131078 16931720 (Pubitemid 44498006)
41. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. Su MW, Yu CL, Burakoff SJ, Jin YJ, J Immunol 2001 166 3975 3982 11238643 (Pubitemid 32224925)
42. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. Guntermann C, Alexander DR, J Immunol 2002 168 4420 4429 11970985 (Pubitemid 34441343)
43. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Zhang Y, Allison JP, Proc Natl Acad Sci USA 1997 94 9273 9278 10.1073/pnas.94.17.9273 9256472 (Pubitemid 27357819)
44. The role of tyrosine phosphorylation and PTP-1C in CTLA-4 signal transduction. Chambers CA, Allison JP, Eur J Immunol 1996 26 3224 3229 10.1002/eji.1830261257 8977326 (Pubitemid 26411535)
45. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. Zhang J, Somani AK, Yuen D, Yang Y, Love PE, Siminovitch KA, J Immunol 1999 163 3012 3021 10477564 (Pubitemid 29431796)
46. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Marengère LE, Waterhouse P, Duncan GS, Mittrücker HW, Feng GS, Mak TW, Science 1996 272 1170 1173 10.1126/science.272.5265.1170 8638161 (Pubitemid 26169471)
47. Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells. Sathish JG, Johnson KG, Fuller KJ, LeRoy FG, Meyaard L, Sims MJ, Matthews RJ, J Immunol 2001 166 1763 1770 11160222 (Pubitemid 32114661)
48. The mouse homologue of the leukocyte-associated Ig-like receptor-1 is an inhibitory receptor that recruits Src homology region 2-containing protein tyrosine phosphatase (SHP)-2, but not SHP-1. Lebbink RJ, de Ruiter T, Verbrugge A, Bril WS, Meyaard L, J Immunol 2004 172 5535 5543 15100296 (Pubitemid 38542055)
49. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Nature 2003 423 506 511 10.1038/nature01621 12724780 (Pubitemid 36648570)
50. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Vijayakrishnan L, Slavik JM, Illés Z, Greenwald RJ, Rainbow D, Greve B, Immunity 2004 20 563 575 10.1016/S1074-7613(04)00110-4 15142525 (Pubitemid 38638126)
51. B7-independent inhibition of T cells by CTLA-4. Chikuma S, Abbas AK, Bluestone JA, J Immunol 2005 175 177 181 15972645 (Pubitemid 40884315)
52. Synergistic inhibition of T-cell activation by a cell-permeable ZAP-70 mutant and ctCTLA-4. Kim KD, Choi JM, Chae WJ, Lee SK, Biochem Biophys Res Commun 2009 381 355 360 10.1016/j.bbrc.2009.02.046 19230824
53. Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis. Choi JM, Kim SH, Shin JH, Gibson T, Yoon BS, Lee DH, Proc Natl Acad Sci USA 2008 105 19875 19880 10.1073/pnas.0805198105 19066215
54. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, Song HM, Nat Med 2006 12 574 579 10.1038/nm1385 16604087
55. Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation. Qureshi OS, Kaur S, Hou TZ, Jeffery LE, Poulter NS, Briggs Z, J Biol Chem 2012 287 9429 9440 10.1074/jbc.M111.304329 22262842
56. CTLA-4 can function as a negative regulator of T cell activation. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Immunity 1994 1 405 413 10.1016/1074-7613(94)90071-X 7882171 (Pubitemid 2134466)
57. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Krummel MF, Allison JP, J Exp Med 1995 182 459 465 10.1084/jem.182.2.459 7543139
58. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells. Wang XB, Zheng CY, Giscombe R, Lefvert AK, Scand J Immunol 2001 54 453 458 10.1046/j.1365-3083.2001.00985.x 11696196 (Pubitemid 32989566)
59. Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors. Wang SF, Fouquet S, Chapon M, Salmon H, Regnier F, Labroquère K, PLoS One 2011 6 17621 10.1371/journal.pone.0017621 21408177
60. The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells. Iype T, Sankarshanan M, Mauldin IS, Mullins DW, Lorenz U, J Immunol 2010 185 6115 6127 10.4049/jimmunol.1000622 20952680
61. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. Gajewski TF, Fallarino F, Fields PE, Rivas F, Alegre ML, J Immunol 2001 166 3900 3907 11238634 (Pubitemid 32224916)
62. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Sansom DM, Walker LS, Immunol Rev 2006 212 131 148 10.1111/j.0105-2896.2006.00419.x 16903911 (Pubitemid 44116705)
63. Impairment in a negative regulatory system for TCR signaling in CD4+ T cells from old mice. Inomata M, Shimada Y, Hayashi M, Shimizu J, Ohno-Iwashita Y, FEBS Lett 2007 581 3039 3043 10.1016/j.febslet.2007.05.063 17559841 (Pubitemid 46899046)
64. Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells. Shimada Y, Hayashi M, Nagasaka Y, Ohno-Iwashita Y, Inomata M, Exp Gerontol 2009 44 517 522 10.1016/j.exger.2009.05.003 19457448
65. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway. Suzuki K, Oneyama C, Kimura H, Tajima S, Okada M, J Biol Chem 2011 286 15698 15706 10.1074/jbc.M110.195362 21388951
66. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Science 1995 270 985 988 10.1126/science.270.5238.985 7481803